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Abstract
Background—When performed competently, colonoscopy screening can reduce colorectal
cancer rates, especially in high-risk groups such as African Americans (AAs). Training primary
care physicians (PCPs) to perform colonoscopy may improve screening rates among underserved
high-risk populations.
Methods—We compared colonoscopy screening rates and computed adjusted odds ratios for
colonoscopy-eligible patients of trained AA PCPs (study group) vs. untrained PCPs (comparison
group), before and since initiating colonoscopy training. All colonoscopies were performed at a
licensed ambulatory surgery center with specialist standby support. Retrospective chart review
was conducted on 200 consecutive, established outpatients aged ≥50 years at each of 12 PCP
offices (7 trained AA PCPs and 5 untrained PCPs, practicing in the same geographic region), total
1,244 study group and 923 comparison group patients.
Results—Post-training colonoscopy rates in both groups were higher than pre-training rates:
48.3% vs. 9.3% in the study group, 29.6% vs. 9.8% in the comparison group (both p<0.001). AA
patients in the study group showed over 5-fold increase (8.9% pre-training vs. 52.8% post
training), with no change among Whites (18.2% vs. 25.0%). Corresponding pre- and post-training
rates among comparison patients were 10.4% and 38.7% respectively among AAs (p<0.001), and
13.3% vs. 13.2% respectively among Whites. After adjusting for demographics, duration since
becoming the PCP’s patient, and health insurance, the study group had a 66% higher likelihood of
colonoscopy in the post-training period (OR=1.66; CI, 1.30, 2.13), and AAs had a five-fold
increased likelihood of colonoscopy relative to Whites.
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Conclusions—Colonoscopy-trained PCPs may help reduce colorectal cancer disparities.
Keywords
Screening colonoscopy; Colorectal cancer screening; African American screening rate;
Colonoscopy-trained primary care physicians
Background
Colorectal cancer (CRC) is a public health priority well-suited to large-scale intervention. It
is the second leading cause of cancer deaths, and has a relatively long latency of 10–15 years
during which incipient, clinically accessible polyps progress to cancer.1 Colonoscopy is a
cost-effective2–6 and a safe outpatient procedure for polyp detection and removal with
proven efficacy for primary prevention.7,8 The at-risk age group is well defined, because
90% of patients with CRC are >50 years old.9 Despite declining CRC mortality among
Whites since 1973, the US Healthy People 2010 goal10 (CRC mortality ≤ 13.9/100,000)
remains elusive due to continuing high CRC incidence and mortality among African
Americans (AA), particularly in the southeastern United States.11
Nationally, African Americans (AA) have 12.3% higher CRC incidence than Whites.12 In
South Carolina, the disparity is worse, with 33% and 30% higher incidence among AA men
and women respectively, and 57% and 40% higher mortality rates, respectively.13
Consistent with the low sensitivity and specificity of the other major CRC screening
modalities [fecal occult blood testing (FOBT) and flexible sigmoidoscopy],14–16 the
American College of Gastroenterology and American Society of Gastrointestinal Endoscopy
prefer colonoscopy over other screening tools.4
The ASGE/ACG guidelines also recommend that AAs begin colonoscopy screening at an
earlier age (45 years) rather than 50 years for normal-risk populations. Colonoscopy is
particularly critical for AAs for several reasons. The majority of AAs with CRC are
diagnosed with advanced disease (57%). 13 AAs present with CRC at younger ages, have
lower 5-year survival (53% v. 63%), experience higher and earlier mortality at all stages of
cancer diagnosis,12 and suffer a higher proportion of proximal colon adenomas that are
missed by sigmoidoscopy.17 Yet, AAs have significantly lower colonoscopy rates than
Whites.1819
This study examined the disparity-reduction potential of a unique program based at a
licensed ambulatory surgery center for colonoscopy in Columbia, South Carolina. In this
program, primary care physicians (PCPs) are trained by a specialist, using training methods
similar to gastroenterology fellowship training, including expert supervision for the
prescribed number of colonoscopies that qualify gastroenterologists for independent practice
privileges.20 In the South Carolina program, however, post-training, the PCPs perform their
cases at the center, follow the center’s procedure and colonic inspection protocols, and are
assisted hands-on by the center’s technical staff. An on-site specialist is available for
completion or rescue assistance (verbal, manual, or technical). Our earlier study documented
the high clinical quality and outcome yield of these procedures, exceeding the prescribed
quality benchmarks for lesion yield (polyps, adenomas and advanced neoplasia rates), cecal
intubation, procedure duration, and adverse events. 20
The current study examined whether patients of colonoscopy-trained AA PCPs have higher
colonoscopy rates than untrained PCPs. Our study’s focus on a primary care outpatient
population is important from a programmatic perspective. Persons with a usual source of
care are more compliant with CRC screening guidelines than the general population;21
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therefore a PCP-focused intervention may help reduce colon cancer disparities. This study
focused on AA physicians because AAs represent the dominant minority in South
Carolina,10,13 and AA physicians are more likely to care for minority patients.22,23
Methods
We compared colonoscopy rates among established patients of purposively sampled AA
PCPs, both trained and untrained in colonoscopy. Our study was designed to test the
following hypotheses: 1) AA patients of colonoscopy-trained AA PCPs have higher
colonoscopy rates than patients of untrained PCPs (comparison group), 2) Among trained
PCPs’ patient panels, post-training rates will be higher than before (initiating) training. We
conducted a retrospective observational study based on patient chart review of age-eligible
patients of colonoscopy-trained AA PCPs (or those in-training) and patients of untrained
PCPs practicing in the same geographic region. All trained PCPs practice within a 70-mile
radius of the endoscopy center where they perform colonoscopies.
Of 54 PCPs who were trained or initiated training under the program, 15 were AA. All 15
were contacted to request study participation, and the first 6 who agreed were included.
Untrained AA PCPs were recruited through professional networks of the trained PCPs,
practicing in the same geographic region. The first 6 untrained PCPs who agreed were
included in the study. Based on statistical power calculations and the documented
characteristics of PCP patient panels,24 we sought samples of 200 established outpatients in
each PCP’s practice, aged >50 years (seeking 1200 patients each from trained and untrained
PCPs, with >90% statistical power to detect a 10% difference).
Each PCP office was requested to provide charts of 200 consecutive, established patients
aged >50 years who most recently completed an office visit relative to the scheduled date for
chart review. “Established patients” were defined as patients seeing the same PCP for at
least one year with at least two visits prior to the current appointment. Data were extracted
without patient identifiers and entered into scan-compatible forms. Research team members
were trained under the University of South Carolina research compliance protocol, and
signed HIPAA confidentiality agreements. Chart reviews focused solely on CRC screening
and were conducted between February and July 2008.
One PCP who had performed 49 colonoscopies as a trainee before discontinuing performing
procedures was mistakenly selected as an untrained physician. His patients were reclassified
into the trained group. One untrained PCP of Asian ethnicity was recruited in error, which
was discovered later. The final PCP sample consisted of 7 trained AA PCPs, and 5 untrained
PCPs (4 AA and 1 Asian). The study was approved by the University of South Carolina
Institutional Review Board.
Determining colonoscopy eligibility status of patients in the pre and post training periods
Cross-sectional and longitudinal comparisons of colonoscopy rates were made as follows: 1)
post-training colonoscopy-eligible patients of trained PCPs (study group) vs. untrained PCPs
(comparison group), and 2) pre vs. post-training colonoscopy-eligibles among the study
group were evaluated against the corresponding time periods among comparison patients
(secular time trends).
For trained PCPs’ patients, the cut-off date to determine pre- and post-training colonoscopy-
eligibility was their PCP’s date of first training colonoscopy. Patients were included in the
pre-training eligible group if they: a) were >50 years old at the training start date; and b) had
an office visit prior to this date; and c) had not completed a colonoscopy prior to their first
visit to this PCP. Patients were post-training colonoscopy-eligible if they belonged to one of
Xirasagar et al. Page 3
Cancer. Author manuscript; available in PMC 2012 November 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
three categories: a) colonoscopy-eligible pre-training, but did not complete a colonoscopy
prior to the training start date; or b) turned 50 years of age after the cut-off date and did not
have a prior colonoscopy; or c) aged ≥51 years by the date of our chart review, and became
a patient of this PCP after the training date, and did not have a prior colonoscopy. For
category c) above, the age criterion allowed one year after their 50th birthday to schedule a
routine physical exam and colonoscopy. By design, pre-training eligible patients who did
not complete colonoscopy in the pre-training period were eligible for inclusion in the post-
training group. (Due to sketchy documentation of other CRC screening tests in patient
records, this information was deemed unreliable for determining colonoscopy-eligibility.)
Untrained PCPs’ patients served as the comparison group to capture the comparable
outpatient community rates in this region in the pre- and post-training periods. The cut-off
date to determine the pre- and post- periods for the comparison group was the training start
date of the trained PCP, matched on practice zip code. Comparison patients were included in
the “pre-training” colonoscopy-eligible group if they: a) were aged >50 years as of the cut-
off date; and b) had an office visit prior to the cut-off date, and c) had not completed
screening colonoscopy prior to their first visit to the PCP. A patient was considered “post-
training” eligible if they belonged to one of three categories: a) colonoscopy-eligible pre-
training but did not get a colonoscopy by the cut-off date; b) turned 50 years of age after the
cut-off date and did not have a prior colonoscopy; or c) reached ≥51 years of age by our
chart review date, became a patient of this PCP after the cut-off date, and did not have a
prior colonoscopy. Untrained PCPs whose zip code did not match a trained PCP were
assigned the mean training start date across all seven trained PCPs as the cut-off date.
Statistical Analysis
Colonoscopy rates were compared using Chi Square or Fisher’s exact tests between: a) post-
training eligibles among the study and companion groups (cross-sectional comparisons); and
b) pre vs. post-training eligibles among the study group, and a similar period comparison
among the comparison group (longitudinal comparisons). Logistic regression was used to
examine the odds of receiving a screening colonoscopy by trained versus untrained PCPs in
both the pre- and post-training periods. We adjusted for age, gender, race, duration of being
the PCP’s patient, and health insurance. Odds ratios and 95% confidence intervals are
presented. SAS version 9.2 (SAS Institute Inc, Cary, North Carolina) was used.
Results
The 7 trained study AA PCPs were similar in age, year/month of starting training and mean
number of annual procedures since starting the training compared to the 8 trained AA PCPs
not included in the study (table not shown). Of 2,371 patient charts reviewed, 92 were
excluded due to missing information on age. Figure 1 shows the exclusions leading up to the
final study sample of 2,167 patients, 1,244 of trained PCPs and 923 of untrained PCPs and
their colonoscopy-eligibility status in the pre- and post-training periods.
Among the trained sample, 483 patients were pre-training colonoscopy-eligible and 1,183
were post-training eligible. Corresponding pre- and post-eligibles in the untrained PCP
patient sample were 234 and 900, respectively (Fewer pre-training eligibles were in the
comparison group because more of the untrained PCPs had moved into the region recently
and had accrued fewer patients qualifying for pre-training inclusion). Training start dates
span a long period, i.e., from October 1999 to July 2006, which in itself enables some
adjustment for secular trends in screening rates.
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The trained vs. comparison patient groups were of similar age in the two time periods (Table
1). In the post-training period; the patients in study group were more likely to be AA (91%
vs. 63%; p<0.001), and on Medicaid or without insurance (12% vs. 7%; p<0.001) relative to
patients among untrained PCPs.
Table 2 presents colonoscopy rates of the study vs. comparison groups. Pre-training rates
were similar between the two groups for the overall sample, among AAs, Whites, men, and
women (all p>0.05). Post-training, the rates among both the study and comparison groups
increased over pre-training levels (9.3% to 48.3% among trained PCPs, p<0.001), and 9.8%
to 29.6% among comparison patients, both p<0.001). Post-training, the trained group rate
was higher than the comparison group rate (48.3% vs. 29.6%; p<0.001), the large increase
was observed among AAs (10.3% pre-training vs.52.8% post training, p<0.0001) with no
statistically significant change among Whites (18.2% vs. 25.0%). Gender-wise, the observed
post-training increase was higher among men, (49.8% post- vs. 8.4% pre-), compared to
women (47.7% post-vs. 10.2% pre-training). Among comparison patients, the increase from
pre- to post- was driven by AAs (10.4% pre vs. 38.7% post), while rates among Whites
remained unchanged (13.3% pre-vs. 13.2% post). The increase from pre- to post- was
greater among women patients in the study group relative to the comparison group (47.7%
vs. 26.7%, p<0.001). Also the increase from pre-to post- in the study group was led by
Medicare and privately insured patients. Notably, Medicaid patients showed a significant
post-training increase in the study group, (3.7% pre- vs. 47.7% post-; p<0.001), with no
corresponding change in the comparison group (0% to 6.7%).
Multiple logistic regression analyses were conducted to examine the colonoscopy odds of
the study vs. comparison patients, pre- and post-training, controlling for demographics,
duration of being the PCP’s patient, and health insurance status (Table 3). Pre-training,
study and comparison patients had a similar colonoscopy likelihood (OR=1.12; 95%
CI=0.58, 2.17), and, AAs were as likely as Whites to have had a colonoscopy (OR=1.26;
95% CI=0.45, 3.56). Post-training, the study group had a significantly higher odds of
colonoscopy (OR=1.66; 95% CI=1.30, 2.13), and AAs were five times more likely to have
had colonoscopy relative to Whites (OR=5.03; 95% CI=3.48, 7.28). A sensitivity analysis
was conducted to evaluate potential confounding by demographic factors. When analyses
were conducted within strata defined by gender, race, and insurance status, the training
effect was undiminished (results not presented).
Table 4 shows that after initiating training the PCP was the provider for the colonoscopy for
79% of patients (slightly more among men than women). Among comparison patients the
provider for almost all colonoscopies was a specialist (data not shown).
Because one of the comparison PCPs (untrained) was Asian, and we were concerned about
the role of race concordance in AA patients’ compliance with a colonoscopy
recommendation, we excluded this PCP in a set of secondary analyses. We found that none
of the results shown in Tables 1–4 were materially affected by the exclusion (tables not
presented).
Discussion
Our study finds that AA PCPs trained in screening colonoscopy have a significant positive
impact on their AA patients’ colonoscopy screening rates. By design, we focused on AA
PCPs’ patients because past studies suggest that minority physicians may be the most
appropriate vehicle through which to address health disparities, particularly when invasive
procedures are involved. Minority patients who perceive race-based medical discrimination
by their provider have lower CRC screening rates than those who do not.25 Race
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concordance is an important driver of minority patients’ trust in their physician, and in the
initiation of CRC-related communication.26 Patient-physician interaction regarding CRC is
critical, because physician recommendation is strongly associated with CRC screening
including colonoscopy.27–29 Studies show that physicians recommend colonoscopy less
frequently for AA patients relative to Whites, even among Medicare beneficiaries.30
Correspondingly, Medicare screening rates are lowest among AA metropolitan beneficiaries,
after adjusting for education and income.31
The utility of mobilizing PCPs to increase CRC screening rates has been documented.32, 33
Because AAs report difficulties in accessing specialist care,34,35 these studies in conjunction
with our findings make a strong case for expanding program innovations that leverage
existing culturally competent patient-PCP connections, particularly race-concordant
relationships.
Consistent with the documented literature, the AA PCPs’ patient panels in our study were
overwhelmingly (about 90%) AA. 22,23 We found that the post-training increase in
colonoscopy screening among patients of AA PCPs was overwhelmingly accounted for by
AA patients who showed a 5-fold increase relative to pre-training (9.3% to 48.3%). Among
comparison patients the corresponding period rates were 9.8% and 29.6% respectively,
which provides the background rate against which to assess the excess increase achieved
among the trained group over time. The increased background rate found in our study is
consistent with the national trend in screening colonoscopies following the Medicare
Benefits and Improvement Act, which authorized coverage of colonoscopy screening.36
Another key finding of our study is that the five-fold increase among AAs is sustained
among AA men, a documented hard-to-reach constituency for screening programs. Finally,
the increased post-training rate among Medicaid patients reinforces the potential utility of
training AA PCPs in colonoscopy as a strategy to reduce AA colonoscopy screening
disparities.
Our findings are significant given the nation-wide gap between specialist availability and the
screening-eligible population, an estimated cumulative backlog of 41.8 million. 37 In South
Carolina alone, over a three-fold increase in the number of specialists is needed to cover all
adults aged over 50 years.38 When demand for a premium service outstrips supply,
underserved populations are disproportionately excluded.39–42 Endoscopic screening rates
among Whites increased between 1995 and 2004, but remained stagnant among AAs
residing in counties with higher uninsurance rates, low PCP supply and high poverty rates,42
characteristics that are typical of most AA communities in the southeastern United States.
Among federally qualified health center patients (mostly poor, minority, or both), a CRC
screening rate of 7% is documented; 94% of these FOBT,41 with similar rates reported in
other studies.43 CRC screening trends among Medicare beneficiaries show worsening of
colonoscopy disparities, and a disproportionate preponderance of FOBT and sigmoidoscopy
among minorities, although the rates of any CRC screening are similar among minorities
and Whites.39 Similar racial disparities in screening modality? among the privately insured
population are observed despite identical insurance coverage.40 The apparent similarity of
AA and White screening rates reported in some studies 39 conceals the hidden disparities in
CRC protection due to the preponderance of de facto low-efficacy screening modalities
(FOBT and sigmoidoscopy) among AAs.
Our study is important because it provides the evidence for a realistic way out of the
compromise approach underlying current screening guidelines. Currently, the FOBT and
flexible sigmoidoscopy (FS) strategies are recommended on par with colonoscopy,44,45
despite significant shortfalls in the primary prevention effectiveness of FOBT and
sigmoidoscopy even under stringent clinical trial conditions, shortfalls that are further
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magnified under community practice conditions. 46–51 The current recommendation of
FOBT, FS and colonoscopy as acceptable screening alternatives is driven by a
gastroenterologist shortage, and sustained by inadequate clarity among stakeholders on the
magnitude of the effectiveness gap between colonoscopy and these alternative tests. Our
current study, together with the earlier study on the clinical quality of PCP colonoscopies20
present an evidence base for reaching underserved populations by expanding colonoscopy
capacity using well-trained PCPs with specialist back-up support. Our studies provide the
evidence for increasing colonoscopy performance capacity in the health system and
concurrently to reach out to underserved populations.
The study has some limitations. Both trained and untrained PCPs were convenience
samples, based on willingness to collaborate. However, the trained PCPs included in this
study were similar on most relevant variables to the trained AA PCPs who were excluded
(table not presented). We have no comparisons for untrained study physicians. The study
also did not assess patients of trained White PCPs, which limits our ability to assess the role
of PCP-patient race-concordance in patients’ adoption of colonoscopy screening. We
observed a much higher rate increase among AA patients while White patients’ rates
remained stagnant following AA PCP’s colonoscopy training, but we do not know the
comparable status of AA and White patients of White PCPs. Future research must explore
this important finding of concern. Another limitation was the lack of reliable data on other
CRC screenings (particularly on being up-to-date) that could cause some patients to be
misclassified as colonoscopy-eligible. Very few patients had an alternative screening test
documented, and consideration of these patients as colonoscopy-ineligible would alter the
pre-training colonoscopy completion rates from 9.3% to 9.6% among trained PCP patients,
and 9.8% to 10.2% among untrained PCPs. Post training the rates would change from 48.3%
to 49.1%, and 29.6% to 29.9% respectively. Our findings remain robust to this limitation.
Another limitation is that despite a nested sample design, multi-level modeling was not
feasible due to too few physicians and imbalanced cell sizes between trained and
comparison groups. Finally, our findings, based on an outpatient, predominantly AA
population may not generalize to the general population and to other racial groups.
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Fig 1.
Sample physicians and patients by inclusion/exclusion criteria, and patients’ colonoscopy-
eligible status in the pre and post training periods
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Table 1
Demographic characteristics of patients who were colonoscopy-eligible in the pre- and post-training periods
(Sampled patients=1244 of trained PCPs, 923 of untrained PCPs; See Figure 1).
Pre-training period Post-training period
Trained PCP Untrained PCP Trained PCP Untrained PCP
No. of colonoscopy-eligible patients 483 234 1183 900
Age* 63.7 62.3 63.4 63.3
Age:
 50–54 99 (21%) 57 (24%) 270 (23%) 209 (23%)
 55–64 181 (37%) 87 (37%) 440 (37%) 342 (38%)
 65–74 127 (26%) 59 (25%) 288 (24%) 200 (22%)
 75+ 76 (16%) 31 (13%0 201 (16%) 149 (17%)
Gender:
 Male 166 (37%) 86 (41%) 438 (39%) 263 (31%)
 Female 285 (63%) 124 (59%) 673 (61%) 574 (69%)§
Race:
 African American 380 (89%) 183 (91%) 919 (91%) 504 (63%)
 Whites/other† 46 (11%) 19 (9%) 89 (9%) 297 (37%)¶
Major Insurance:
 Medicaid 27 (6%) 2 (1%) 65 (6%) 30 (4%)
 Medicare 194 (44%) 95 (45%) 398 (36%) 258 (31%)
 Private/VA‡ 205 (46%) 113 (53%) 595 (53%) 509 (62%)
 Uninsured 18 (4%) 3 (1%)* 62 (6%)* 27 (3%)§
*
Mean age is the interval between the patient’s date of birth and the PCP’s training start date for the Pre-training period group, and the survey date
for the post-training period.
†
Whites/other includes 2.3% Hispanics and 1.4% other.
‡
Private includes 5% other insurance type such as Veterans Administration.
§
p < 0.05, and
¶
p < 0.0001 for the Chi Square or Fisher’s exact test of homogeneity comparing characteristics of patients of trained vs. untrained physicians
within each period.
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Table 3
Adjusted colonoscopy odds of trained vs. untrained PCP patients, during the pre-training and post-training
periods
Pre-training Period Post-training Period
Variables* Colonoscopy Odds OR (95% CI) Colonoscopy Odds OR (95% CI)
PCP training status (Yes vs. No) 1.12 (0.58, 2.17) 1.66 (1.30, 2.13) §
Age 50–54 0.42 (0.15, 1.14) 1.19 (0.81, 1.74)
Age 55–64 0.51 (0.22 1.18) 2.02 (1.43, 2.85) ‡
Age 65–74 0.82 (0.36, 1.89) 1.93 (1.33, 2.79) ‡
Gender 0.90 (0.49, 1.66) 0.80 (0.64, 1.02)
Race 1.26 (0.45, 3.56) 5.03 (3.48, 7.28) §
Health insurance (no vs. yes) -† 0.22 (0.10, 0.46) §
Duration of being PCP’s patient <3 years 2.05 (0.96, 4.37) 1.63 (1.23, 2.16) §
Duration of being PCP’s patient ≥3 and ≤10 years 1.50 (0.73, 3.11) 0.64 (0.48, 0.85)
*
Referent categories are: age ≥75 years; gender female; race Whites; health insurance – yes; and duration of being this PCP’s patient >10 years.
†
The “Pre-training period” model did not include “insurance status” because of a zero colonoscopy rate among the uninsured in the pre period and
the resulting model instability.
‡
p=<0.01;
§
p=<0.0001
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Table 4
Source of colonoscopy service, PCP or specialist for patients of trained PCPs, post training, by patient
characteristics.
Patient characteristic PCP performed Specialist performed
Race/ethnicity
 African American 354 (78.5%) 97 (21.5%)
 Whites 17 (81.0%) 4 (19.1%)
Gender
 Male 170 (82.9%) 35 (17.1%)
 Female 223 (75.6%) 72 (24.4%)*
Insurance
 Medicaid 23 (79.3%) 6 (20.7%)†
 Medicare 145 (79.2%) 38 (20.8%)†
 Private 229 (78.2%) 64 (21.8%)†
 Uninsured 4 (80.0%) 1 (20.0%)
*
p ≤ 0.05 for the Chi Square test of independence comparing the males and females among specialist-performed colonoscopy.
†
p ≤ 0.001 for the Chi Square test of independence comparing PCP vs. specialist-performed colonoscopy.
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